
Loading, please wait...

Loading, please wait...

The Delhi High Court recently addressed a significant concern regarding EWS healthcare access at the Institute of Liver and Biliary Sciences (ILBS). Specifically, a bench led by Chief Justice D. K. Upadhyaya sought the Delhi government's stand on a new Public Interest Litigation (PIL). Currently, this plea challenges the current policy limiting free treatment for Economically Weaker Section (EWS) patients to only 10% of beds. NGO Social Justice filed the petition to highlight critical treatment allocation discrepancies at the institute.
Instead, Advocate Satyakam argued that ILBS is a premier, government-funded institution. It specializes in treating complex liver diseases like cirrhosis and cancer. Therefore, he submitted that it cannot operate as a predominantly paid medical facility. The petitioner claims the current policy is arbitrary and unreasonable. Furthermore, they argue it violates Articles 14 and 21 of the Constitution. Essentially, this creates a divide between affluent and indigent patients regarding essential care.
The NGO asserts that private hospitals on concessional land must provide at least a 10% IPD reservation. Consequently, a fully state-owned hospital providing only the same benefit appears insufficient to the public interest. The PIL emphasizes that the Supreme Court mandates equitable EWS healthcare access without commercial barriers. Thus, the NGO seeks a direction to quash the existing ILBS policy. Additionally, they suggest that 100% of beds should be free for the general public. Alternatively, the quota should increase to at least 50%.
The court has scheduled the next hearing for April 22, 2026. Meanwhile, the respondents must file their formal responses to the legal notice. This case highlights ongoing legal scrutiny over public healthcare obligations in the capital. Recently, the Delhi government enhanced the EWS income threshold to Rs 5 lakh per annum. Ultimately, this shift aims to provide more vulnerable families with necessary medical support in identified hospitals.
Q1: What is the current EWS treatment quota at ILBS?
Currently, the Institute of Liver and Biliary Sciences (ILBS) reserves 10% of beds in the in-patient department (IPD) and 25% of cases in the out-patient department (OPD) for free treatment of economically weaker sections (EWS).
Q2: Why is the NGO Social Justice challenging the ILBS policy?
The NGO argues that as a fully government-funded institution, ILBS should not follow the same minimum quota as private hospitals built on concessional land. They seek either 100% free services or a significant increase in the EWS quota to ensure equitable healthcare access for the poor.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Delhi High Court has issued a notice regarding a PIL challenging the limited EWS bed reservation at ILBS, seeking equitable healthcare access for the po...
5 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today